0001493152-23-029825.txt : 20230822
0001493152-23-029825.hdr.sgml : 20230822
20230822161018
ACCESSION NUMBER: 0001493152-23-029825
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230818
FILED AS OF DATE: 20230822
DATE AS OF CHANGE: 20230822
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Carey Robert
CENTRAL INDEX KEY: 0001602064
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38892
FILM NUMBER: 231193565
MAIL ADDRESS:
STREET 1: HORIZON PHARMA, INC.
STREET 2: 520 LAKE COOK ROAD, SUITE 520
CITY: DEERFIELD
STATE: IL
ZIP: 60062
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Beyond Air, Inc.
CENTRAL INDEX KEY: 0001641631
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 473812456
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 900 STEWART AVENUE
STREET 2: SUITE 301
CITY: GARDEN CITY
STATE: NY
ZIP: 11530
BUSINESS PHONE: 516-665-8200
MAIL ADDRESS:
STREET 1: 900 STEWART AVENUE
STREET 2: SUITE 301
CITY: GARDEN CITY
STATE: NY
ZIP: 11530
FORMER COMPANY:
FORMER CONFORMED NAME: AIT Therapeutics, Inc.
DATE OF NAME CHANGE: 20170117
FORMER COMPANY:
FORMER CONFORMED NAME: KokiCare, Inc.
DATE OF NAME CHANGE: 20150507
4
1
ownership.xml
X0508
4
2023-08-18
0
0001641631
Beyond Air, Inc.
XAIR
0001602064
Carey Robert
C/O BEYOND AIR, INC.
900 STEWART AVENUE, SUITE 301
GARDEN CITY
NY
11530
1
0
0
0
0
Common Stock
2023-08-18
4
P
0
13614
2.6399
A
900110
D
Common Stock
2023-08-21
4
P
0
75050
2.7642
A
975160
D
This price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.635 to $2.64, inclusive. The reporting person undertakes to provide to Beyond Air, Inc., any security holder of Beyond Air, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.
This price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.655 to $2.78, inclusive. The reporting person undertakes to provide to Beyond Air, Inc., any security holder of Beyond Air, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (2) to this Form 4.
/s/ Robert Carey
2023-08-22